10.4.2026 – UMBI Research Updates Series (RUS) in Molecular Medicine

10 April 2026 | The ð‘ðžð¬ðžðšð«ðœð¡ ð”ð©ððšð­ðž ð’ðžð«ð¢ðžð¬ ð¢ð§ ðŒð¨ð¥ðžðœð®ð¥ðšð« ðŒðžðð¢ðœð¢ð§ðž ðð¨.ðŸðŸŽ/ðŸðŸŽðŸðŸ” was successfully held earlier this morning, featuring engaging knowledge sharing presentations by two of UMBI’s Research Fellows.
Ìý
ðƒð«. ð“ðšð§ ð’ð¡ð¢ð§ð  ð‚ð¡ðžð§ð  presented on ð¦ð¨ð¥ðžðœð®ð¥ðšð« ð›ð¢ð¨ð¦ðšð«ð¤ðžð«ð¬ ð¨ðŸ ðœðšð§ðœðžð«, highlighting their clinical significance in diagnosis, prognosis, and treatment guidance, while addressing current limitations and the need for more sensitive, specific, and minimally invasive approaches.
ð“ð¬. ðƒð«. ð’ðšð¢ðŸð®ð¥ ð„ðŸðŸðžð§ðð¢ ð’ð²ðšðŸð«ð®ððð¢ð§ shared insights on ðœð¥ðžðšð« ðœðžð¥ð¥ ð«ðžð§ðšð¥ ðœðžð¥ð¥ ðœðšð«ðœð¢ð§ð¨ð¦ðš (ðœðœð‘ð‚ð‚), focusing on glucocorticoid receptor (GR) signaling and its role in driving oncogenic transcriptional programs. The session underscored key molecular targets and the application of advanced tools such as CRISPR-based approaches in validating these pathways.
Ìý
The session concluded with an engaging Q&A, reflecting the strong interest and active participation of attendees. Thank you to all participants for your active engagement and continued support!

—
SDG 4 – Quality Education